Frontlight ResearchEarly access
CompletedNo phase
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
Key facts
- Who runs it
- Columbia University
- Where
- Itasca, New York, and Philadelphia, United StatesSee the 4 sites
- Trial code
- Status
- Completed
- People taking part
- 66,147 people enrolled
- Started
- 2 Oct 2024
- Ended
- 30 Apr 2025
- Type of study
- Interventional, 4 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Text message influenza vaccine reminders
- Text message COVID-19 vaccine reminders
- Text message influenza and COVID-19 vaccine reminders
- Record updated
- 11 July 2025
Who can take part
- Age
- 6 months to 17 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Child that:; is 6 months-17 year-old children; due for both a COVID-19 and influenza vaccine
- Receives care at study site
- Language listed in electronic health record is English or Spanish
- Has not opted out of text messages from practice
Who cannot take part
- Has opted out of text messages from practice
- Language listed in electronic health record is not English or Spanish
Where in United States
- American Academy of PediatricsItasca, United States
- Columbia University Irving Medical CenterNew York, United States
- Children's Hospital of PhiladelphiaPhiladelphia, United States
- University of PennsylvaniaPhiladelphia, United States
About the trial
What the trial wants to find out
This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.
The 4 groups in the trial
- Text message influenza and COVID-19 vaccine remindersTreatment being tested
Text message reminders for both influenza and COVID-19 vaccinations
- Text message influenza vaccine remindersTreatment being tested
Text message reminders only for influenza vaccination
- Text message COVID-19 vaccine remindersTreatment being tested
Text message reminders only for COVID-19 vaccination
- Usual CareNo study treatment, for comparison
Usual care has no text message
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Text4Vax: Understanding the Effectiveness and Implementation of Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-2025 Season
- Record updated
- 11 July 2025